Radiotheranostics in oncology: current challenges and emerging opportunities

L Bodei, K Herrmann, H Schöder, AM Scott… - Nature Reviews …, 2022 - nature.com
Structural imaging remains an essential component of diagnosis, staging and response
assessment in patients with cancer; however, as clinicians increasingly seek to …

Exploiting RIG-I-like receptor pathway for cancer immunotherapy

Y Jiang, H Zhang, J Wang, J Chen, Z Guo, Y Liu… - Journal of Hematology & …, 2023 - Springer
RIG-I-like receptors (RLRs) are intracellular pattern recognition receptors that detect viral or
bacterial infection and induce host innate immune responses. The RLRs family comprises …

[HTML][HTML] Antibodies against endogenous retroviruses promote lung cancer immunotherapy

KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha… - Nature, 2023 - nature.com
B cells are frequently found in the margins of solid tumours as organized follicles in ectopic
lymphoid organs called tertiary lymphoid structures (TLS),. Although TLS have been found to …

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

M Thibaudin, JD Fumet, B Chibaudel, J Bennouna… - Nature Medicine, 2023 - nature.com
Although patients with microsatellite instable metastatic colorectal cancer (CRC) benefit from
immune checkpoint blockade, chemotherapy with targeted therapies remains the only …

[HTML][HTML] Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients …

N Zhang, H Zhang, W Wu, R Zhou, S Li, Z Wang… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs)
involved in the regulation of the immune system and displayed a cell-type-specific pattern in …

The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy

J Stagg, E Golden, E Wennerberg, S Demaria - Science immunology, 2023 - science.org
The extracellular nucleoside adenosine reduces tissue inflammation and is generated by
irreversible dephosphorylation of adenosine monophosphate (AMP) mediated by the …

Colorectal cancer immunotherapy-Recent progress and future directions

W Zhao, L Jin, P Chen, D Li, W Gao, G Dong - Cancer letters, 2022 - Elsevier
Compared with conventional chemotherapy and targeted therapy, immunotherapy has
changed the treatment prospects of various solid tumors and has recently become the main …

Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer

DM Borràs, S Verbandt, M Ausserhofer, G Sturm, J Lim… - Cell Discovery, 2023 - nature.com
CD8+ T cell activation via immune checkpoint blockade (ICB) is successful in microsatellite
instable (MSI) colorectal cancer (CRC) patients. By comparison, the success of …

Radiation therapy-induced remodeling of the tumor immune microenvironment

M Charpentier, S Spada, SJ Van Nest… - Seminars in Cancer …, 2022 - Elsevier
The tumor immune microenvironment is a determinant of response to cancer
immunotherapy and, in many cases, is prognostic for patient survival independently of the …

Extracellular vesicles as next generation immunotherapeutics

DW Greening, R Xu, A Ale, CE Hagemeyer… - Seminars in Cancer …, 2023 - Elsevier
Extracellular vesicles (EVs) function as a mode of intercellular communication and
molecular transfer to elicit diverse biological/functional response. Accumulating evidence …